Scopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society Scopus BioPharma's Subsidiary - Duet Therapeutics - to Present at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society (09.22.21) FINAL
China National Intellectual Property Administration Grants New Patent Covering DUET-02, One of Three Key CpG-STAT3 Inhibitors Comprising the Duet Platform China National Intellectual Property Administration Grants New Patent Covering DUET-02 (09.21.21) FINAL
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory Board Scopus BioPharma's Subsidiary - Duet Therapeutics - Announces Appointments of John Rossi and Nagy Habib to the Scientific Advisory Board (09.14.21) FINAL
Scopus BioPharma to Present at H.C. Wainwright 23rd Annual Global Investment Conference Scopus BioPharma to Present at H.C. Wainwright 23rd Annual Global Investment Conference (09.09.21) FINAL
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific Advisor Scopus BioPharma's Subsidiary - Duet Therapeutics - Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific Advisor (09.07.21) FINAL
Scopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium Meeting Scopus BioPharma's Subsidiary - Duet Therapeutics - to Present at the 14th Annual RNA Consortium Meeting (09.03.21)
